⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Ergotamine + caffeine
ارگوتامین + کافئین (کافرگوت)
🧠 Nervous SystemErgot alkaloid for migraine
🤰 Pregnancy:Contraindicated🤱 Breastfeeding:Use with caution👶 Children:Safety not established 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA040590ATC N02CA52
Market / country: 🇺🇸 USA
Cafergot (US)
🧮 Dose calculator
Acute migraine attack · Regimen source: FDA Cafergot · Dosage and Administration
- • Max 6 tablets per attack and 10 per week. FDA Cafergot · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy; peripheral vascular or coronary disease; hypertension; impaired hepatic or renal function; sepsis; hypersensitivity; potent CYP3A4 inhibitors. FDA Cafergot · Contraindications
Warnings
- • Boxed warning: with potent CYP3A4 inhibitors (clarithromycin, erythromycin, ritonavir, ketoconazole, itraconazole) serious cerebral or limb ischaemia. FDA Cafergot · Boxed Warning
Formulations
- Ergotamine tartrate 1 mg + caffeine 100 mg tablet — tablet 🇺🇸 USA FDA Cafergot · How Supplied
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Cafergot · CONTRAINDICATIONS
“Ergotamine tartrate and caffeine tablets is contraindicated in women who are or may become pregnant.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cafergot · Nursing Mothers
“Ergot drugs are known to inhibit prolactin but there are no reports of decreased lactation with ergotamine tartrate and caffeine.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Cafergot · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA040590
- DailyMed (FDA label)FDA Cafergot
- MedlinePlus (NIH)Ergotamine and Caffeine
- WHO ATC/DDDN02CA52
- Darooyab (Iran)Ergotamine-C
🇮🇷 Registered in Iran Darooyab · G-4523/Ergotamine-C
Dosage forms with Iranian generic codes, per Darooyab.
- 00493 · ERGOTAMINE C TAB · قرص ارگوتامین C
- 00494 · ERGOTAMINE COMPOUND TAB · قرص ارگوتامین ترکیبی
- 02044 · ERGOTAMINE TARTRATE 2MG SUBLINGUAL TAB · قرص زیرزبانی ارگوتامین تارتارات ۲ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cafergot · How SuppliedFDA Cafergot · Dosage and AdministrationFDA Cafergot · ContraindicationsFDA Cafergot · Boxed WarningFDA Cafergot · CONTRAINDICATIONSFDA Cafergot · Nursing MothersFDA Cafergot · Pediatric UseFDA Cafergot · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4523/Ergotamine-C
- Clinical review⚠ Unverified